logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Fulltext. The costs and effects of cervical and breast cancer screening in a public hospital emergency room.

    Article - En anglais

    Fulltext.

    Objectives

    This study assessed the cost-effectiveness of cervix and breast cancer screening in a public hospital emergency room.

    Methods

    Age-eligible women with nonurgent conditions and without recent screening were offered screening by a nurse.

    A decision analysis compared the costs and outcomes of emergency room screening and standard hospital screening efforts.

    Results

    The undiscounted cost-effectiveness results for establishing new programs were $4050 (cervical cancer), $403203 (breast cancer), and $4375 (joint cervix and breast cancer) per year of life saved.

    If screening is added to an existing program, results are more favorable ($429, $21 324, and $479 per year of life saved for cervix, breast, and joint screening, respectively).

    Results were most sensitive to volume and probability of receiving treatment after an abnormal screen.

    Conclusions

    Emergency room screening was cost-effective for cervical cancer ; breast cancer screening was relatively expensive given the low number of women reached.

    More intensive recruitment and follow-up strategies are needed to maximize the cost-effectiveness of such programs.

    Mots-clés Pascal : Tumeur maligne, Col utérus, Glande mammaire, Dépistage, Service hospitalier, Urgence, Analyse coût efficacité, Femme, Homme, Prévention, Etude comparative, Etats Unis, Amérique du Nord, Amérique, Appareil génital femelle pathologie, Col utérus pathologie, Glande mammaire pathologie

    Mots-clés Pascal anglais : Malignant tumor, Uterine cervix, Mammary gland, Medical screening, Hospital ward, Emergency, Cost efficiency analysis, Woman, Human, Prevention, Comparative study, United States, North America, America, Female genital diseases, Uterine cervix diseases, Mammary gland diseases

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0447510

    Code Inist : 002B30A03B. Création : 03/02/1998.